BlackRock Updates Elevance Health Stake in SC 13G/A Filing
Ticker: ELV · Form: SC 13G/A · Filed: 2024-02-12T00:00:00.000Z
Sentiment: neutral
Topics: institutional-ownership, amendment, healthcare, passive-investment
TL;DR
**BlackRock just updated its Elevance Health stake, signaling its latest position.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on February 12, 2024, indicating its ownership of Elevance Health, Inc. (formerly Anthem, Inc.) common stock as of December 31, 2023. This filing, Amendment No. 14, updates their previous disclosures regarding their stake in the healthcare company. This matters to investors because BlackRock is a major institutional investor, and changes in their reported holdings can signal shifts in their investment strategy or outlook on Elevance Health's future performance.
Why It Matters
This filing shows BlackRock's continued significant, though potentially adjusted, investment in Elevance Health, which can influence market perception and investor confidence.
Risk Assessment
Risk Level: low — This is a routine disclosure filing by a large institutional investor and does not inherently indicate a high level of risk.
Analyst Insight
Investors should note BlackRock's continued presence as a significant shareholder in Elevance Health, but this filing alone doesn't provide enough detail to infer a specific bullish or bearish action. Further analysis of BlackRock's full 13F filing (when available) would be needed to see the exact change in share count.
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- Elevance Health, Inc. (company) — the subject company whose common stock is being reported
- Anthem, Inc. (company) — former name of Elevance Health, Inc.
- December 31, 2023 (date) — the date of the event which required the filing
- February 12, 2024 (date) — the filing date of the SC 13G/A
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as stated in the 'FORM TYPE: SC 13G/A' and 'SCHEDULE 13G (Amendment No: 14)' sections.
Who is the reporting person in this filing?
The reporting person, or the entity that filed this document, is BlackRock Inc., as indicated under the 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc.' section.
What company's securities are being reported on?
The securities being reported on belong to Elevance Health, Inc., as stated under 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Elevance Health, Inc.' and 'Elevance Health, Inc. (Name of Issuer)'.
What was the date of the event that triggered this filing?
The date of the event which required the filing of this statement was December 31, 2023, as specified under '(Date of Event Which Requires Filing of this Statement)'.
Under which SEC rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13d-1(b), as indicated by the '[X] Rule 13d-1(b)' checkbox.
From the Filing
0001086364-24-006968.txt : 20240212 0001086364-24-006968.hdr.sgml : 20240212 20240212123301 ACCESSION NUMBER: 0001086364-24-006968 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240212 DATE AS OF CHANGE: 20240212 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Elevance Health, Inc. CENTRAL INDEX KEY: 0001156039 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 352145715 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-80503 FILM NUMBER: 24618582 BUSINESS ADDRESS: STREET 1: 220 VIRGINIA AVENUE CITY: INDIANAPOLIS STATE: IN ZIP: 46204 BUSINESS PHONE: 8003311476 MAIL ADDRESS: STREET 1: 220 VIRGINIA AVENUE CITY: INDIANAPOLIS STATE: IN ZIP: 46204 FORMER COMPANY: FORMER CONFORMED NAME: Anthem, Inc. DATE OF NAME CHANGE: 20141202 FORMER COMPANY: FORMER CONFORMED NAME: WELLPOINT, INC DATE OF NAME CHANGE: 20100105 FORMER COMPANY: FORMER CONFORMED NAME: WELLPOINT INC DATE OF NAME CHANGE: 20041130 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc. CENTRAL INDEX KEY: 0001364742 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211] ORGANIZATION NAME: 02 Finance IRS NUMBER: 320174431 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 50 HUDSON YARDS CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 212-810-5300 MAIL ADDRESS: STREET 1: 50 HUDSON YARDS CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: BlackRock, Inc. DATE OF NAME CHANGE: 20060929 FORMER COMPANY: FORMER CONFORMED NAME: New BlackRock, Inc. DATE OF NAME CHANGE: 20060601 SC 13G/A 1 us0367521038_021224.txt us0367521038_021224.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 14) Elevance Health, Inc. -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 036752103 -------------------------------------------------------- (CUSIP Number) December 31, 2023 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 036752103 (1)Names of reporting persons. BlackRock, Inc. (2) Check the appropriate box if a member of a group (a) [ ] (b) [X] (3) SEC use only (4) Citizenship or place of organization Delaware Number of shares beneficially owned by each reporting person with: (5) Sole voting power 18956651 (6) Shared voting power 0 (7) Sole dispositive power 21044185 (8) Shared dispositive power 0 (9) Aggregate amount beneficially owned by each reporting person 21044185 (10) Check if the aggregate amount in Row (9) excludes certain shares (11) Percent of class represented by amount in Row 9 9.0% (12) Type of reporting person HC Item 1. Item 1(a) Name of issuer: ----------------------------------------------------------------------- Elevance Health, Inc. Item 1(b) Address of issuer's principal executive offices: ----------------------------------------------------------------------- 220 VIRG